MusclePharm
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of MusclePharm generated cash of -$8,042,000, which is less than the previous year. Cash used in financing activities reached the amount of $7,264,000 last year. Net change in cash is therefore -$780,000.
Cash Flow
| 2012 | -697.59K | -965.32K | 1.01M |
|---|---|---|---|
| 2013 | -9.97M | -3.52M | 18.91M |
| 2014 | -4.13M | -1.6M | 1.39M |
| 2015 | 5.49M | -3.04M | 3.72M |
| 2016 | -15.06M | 5.39M | 7.52M |
| 2017 | -5.13M | -37K | 6.43M |
| 2018 | 1.98M | -132K | -5.72M |
| 2019 | -6.52M | -13K | 5.74M |
| 2020 | -868K | 218K | 1.12M |
| 2021 | -8.04M | -2K | 7.26M |
MSLP Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 2.00M | 1.53M | 2.31M | 6.22M | 4.94M | 7.08M | 1.02M | 5.41M | 0 | 659.76K |
Operating activities | ||||||||||
Net income | -12.86M | 3.18M | -18.92M | -10.75M | -10.97M | -3.47M | -51.85M | -13.83M | -17.71M | -18.95M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 331K | 465K | 659K | 849K | 1.46M | 2.12M | 2.81M | 1.98M | 708.97K | 475.32K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.56M | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.56M | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 625K | -2.85M | 1.44M | 1.93M | -4.61M | 7.33M | -5.57M | -2.60M | -10.68M | -742.74K |
Inventories | -702K | 3.68M | 8.85M | -3.93M | 2.12M | -480K | 5.92M | -4.46M | -16.33M | -616.77K |
Accounts payable | 3.26M | -4.70M | -70K | 11.51M | 1.99M | -9.92M | 14.22M | -31K | -573.90K | 0 |
Cash generated by operating activities | -8.04M | -868K | -6.52M | 1.98M | -5.13M | -15.06M | 5.49M | -4.13M | -9.97M | -697.59K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | -977K | 0 | -2.27M | 0 |
Investments In Property Plant And Equipment | -2K | -4K | -13K | -132K | -37K | -508K | -2.58M | -4.59M | -1.91M | -924.16K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -2K | 218K | -13K | -132K | -37K | 5.39M | -3.04M | -1.6M | -3.52M | -965.32K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 204K | 702K | 0 | 0 | 6K | 0 | 0 | 10.55M | 1.66M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.92M | -1.03M | -460.97K |
Repayments of term debt | -49.98M | -47.46M | 0 | -42.66M | 0 | -47.40M | 0 | -2.60M | -4.40M | -5.84M |
Cash used in financing activities | 7.26M | 1.12M | 5.74M | -5.72M | 6.43M | 7.52M | 3.72M | 1.39M | 18.91M | 1.01M |
Net Change In Cash | -780K | 471K | -785K | -3.91M | 1.28M | -2.13M | 6.06M | -4.39M | 5.41M | 0 |
Cash at end of period | 1.22M | 2.00M | 1.53M | 2.31M | 6.22M | 4.94M | 7.08M | 1.02M | 5.41M | 0 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |